Citation Impact
Citing Papers
Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.
1994
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Activation of human inflammatory cells by secreted phospholipases A2
2006
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Variabilin: A Dual Inhibitor of Human Secretory and Cytosolic Phospholipase A2 With Anti-inflammatory Activity
1997
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
1998 Standout
Inflammation and Alzheimer's disease
2000 Standout
Drugs from the deep: marine natural products as drug candidates
2003 Standout
Current research on acute phase proteins in veterinary diagnosis: an overview
2003 Standout
A potentially critical role of phospholipases in central nervous system ischemic, traumatic, and neurodegenerative disorders
2004
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
2008 Standout
Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis
2002
Acute phase proteins in dogs and cats: current knowledge and future perspectives
2005 Standout
Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity
2009
Stress system response and rheumatoid arthritis: a multilevel approach
1999
Epidemiology of COPD
2009 Standout
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
1998 Standout
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Inflammatory response to cardiopulmonary bypass
1993 Standout
Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect
2014
Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept
2005
Etanercept and efalizumab for the treatment of psoriasis: a systematic review
2006
Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2
1999
Structures, Enzymatic Properties, and Expression of Novel Human and Mouse Secretory Phospholipase A2s
2000
Selective inhibition of group II phospholipase A2 by quercetin
1993
Anti-inflammatory Plant Flavonoids and Cellular Action Mechanisms
2004 Standout
Macrophages in atherosclerosis: a dynamic balance
2013 Standout
Checking consistency in mixed treatment comparison meta‐analysis
2010 Standout
Inactivation of human synovial fluid phospholipase a2 by the marine natural product, manoalide
1990
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Serum amyloid A, the major vertebrate acute‐phase reactant
1999
Interleukin-1 and Its Biologically Related Cytokines
1989
Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity
1997
Structure-antioxidant activity relationships of flavonoids and phenolic acids
1996 Standout
Acute phase reaction and acute phase proteins
2005 Standout
Ankylosing spondylitis
2007 Standout
Adipokines: inflammation and the pleiotropic role of white adipose tissue
2004 Standout
Advances and Challenges of Liposome Assisted Drug Delivery
2015 Standout
Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis
2002 Standout
Secretory phospholipase A2 of group IIA: Is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?
2005
The phospholipase A2 superfamily and its group numbering system
2006 Standout
Platelets and the immune continuum
2011 Standout
Successful Treatment of Dermatomyositis and Polymyositis with Anti-Tumor-Necrosis-Factor-Alpha: Preliminary Observations
2003
Tumor necrosis factor-? in the pathogenesis and treatment of cancer
2004
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
2009 Standout
Secretory phospholipases A2 induce cytokine release from blood and synovial fluid monocytes
2002
The expanding superfamily of phospholipase A2 enzymes: classification and characterization
2000 Standout
Atherosclerosis
2000 StandoutNature
One‐year open‐label trial of thalidomide in ankylosing spondylitis
2002
Prostaglandin synthase 2
1996 Standout
Oxidative stress and neurodegeneration: where are we now?
2006 Standout
Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy
2002
Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis
1988
119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands
2004 Standout
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Therapeutic potential of cytokine and chemokine antagonists in cancer therapy
2006
A Novel Polymorphism in Secretory Phospholipase A 2 -IID Is Associated with Body Weight Loss in Chronic Obstructive Pulmonary Disease
2005
Activation of Cytokine Production by Secreted Phospholipase A2 in Human Lung Macrophages Expressing the M-Type Receptor
2005
Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
1996
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. Possible participation of cytosolic and extracellular type II phospholipases A2.
1993
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
1996 Standout
Group IB Secretory Phospholipase A2 Stimulates CXC Chemokine Ligand 8 Production via ERK and NF-κB in Human Neutrophils
2004
Anti-interleukin-1 and anti-tumor necrosis factor-α synergistically inhibit adjuvant arthritis in Lewis rats
2000
Risk of malignancy among patients with rheumatic conditions
2000
Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response
1991
Erythropoietin: Biology and Clinical Use
1989
Erythropoietin
1991 Standout
The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
2002
Human Secretory Phospholipase A2Mediates Decreased Plasma Levels of HDL Cholesterol and ApoA-I in Response to Inflammation in Human ApoA-I Transgenic Mice
2002
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
Cloning and Characterization of Novel Mouse and Human Secretory Phospholipase A2s
1999
Circulating Levels of Secretory Type II Phospholipase A 2 Predict Coronary Events in Patients with Coronary Artery Disease
1999
Works of Keystone Ec being referenced
The role of tumor necrosis factor antagonism in clinical practice.
1999
Malignancy in progressive systemic sclerosis--association with breast carcinoma.
1983
Serial levels of soluble interleukin 2 receptor in the peripheral blood of patients with rheumatoid arthritis: correlations with disease activity.
1990
Thalidomide in the treatment of refractory rheumatoid arthritis.
1999
The safety of biologic agents in early rheumatoid arthritis.
2004
Secretory phospholipase A2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients.
1996
Interleukin abnormalities in recently active rheumatoid arthritis.
1984
Interleukin 1 and interleukin 2 generation by peripheral blood cells from patients with ankylosing spondylitis.
1986
Serum phospholipase A2 correlates with disease activity in rheumatoid arthritis.
1988